Table 1 Demographic and baseline characteristics of participants with or without cardiovascular deaths
From: The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population
|  | No cardiovascular death (n = 12,290) | Cardiovascular death (n = 150) | P value |
|---|---|---|---|
Age (years) | 46.0 (31.0, 62.0) | 75.0 (65.3, 80.0) | < 0.001 |
Age group | |||
 < 65 years | 9779 (79.6%) | 33 (22.0%) | < 0.001 |
 ≥ 65 years | 2511 (20.4%) | 117 (78.0%) | |
Gender | |||
 Male | 5936 (48.3%) | 98 (65.3%) | < 0.001 |
 Female | 6354 (51.7%) | 52 (34.7%) | |
Race | |||
 Mexican American | 2081 (16.9%) | 15 (10.0%) | < 0.001 |
 Non-Hispanic white | 5299 (43.1%) | 93 (62.0%) | |
 Non-Hispanic black | 2596 (21.1%) | 29 (19.3%) | |
 Other races | 2314 (18.8%) | 13 (8.7%) | |
Drinking | 8774 (71.4%) | 107 (71.3%) | 0.988 |
Smoking | 5402 (44.0%) | 89 (59.3%) | < 0.001 |
Hypertension | 4586 (37.3%) | 110 (73.3%) | < 0.001 |
Diabetes | 1879 (15.3%) | 48 (32.0%) | < 0.001 |
CAD | 1288 (10.5%) | 35 (23.3%) | < 0.001 |
Stroke | 681 (5.5%) | 19 (12.5%) | 0.011 |
Lipid-lowering drugs | 2588 (21.1%) | 67 (44.7%) | < 0.001 |
TC (mmol/L) | 4.86 (4.19, 5.59) | 4.82 (4.09, 5.61) | 0.563 |
TG (mmol/L) | 1.15 (0.81, 1.69) | 1.33 (1.02, 2.04) | < 0.001 |
HDL-C (mmol/L) | 1.34 (1.11, 1.63) | 1.27 (1.09, 1.58) | 0.121 |
LDL-C (mmol/L) | 2.85 (2.28, 3.50) | 2.76 (2.07, 3.47) | 0.191 |
ApoB (mg/dL) | 89.0 (73.0, 107.0) | 96.0 (75.0, 113.5) | 0.049 |
LAR | 1.25 (1.12, 1.35) | 1.13 (1.01, 1.24) | < 0.001 |